Market:
Materials used in space travel have not changed since the times of the Apollo Missions and new extreme materials are needed for extreme flight conditions. Nanoarmor addresses this market that will grow from $250 million today to $3 billion by 2026.Technology:
Through a close research partnership with the Naval Research Laboratory, Nanoarmor has exclusively licensed an advanced IP portfolio built up over the last 10 years. We are developing the additive manufacturing capabilities to deliver the ultra-high-temperature materials needed for ultra-high-speed travel on Earth and in the universe beyond.Advantages:
- Lower processing costs
- Faster production
- Higher melting temperatures
- 3D-printed custom parts
- Custom materials for customer requirements
Development Stage:
- Prototype
Patents Issued
- Refractory Metal Ceramics and Methods of Making Thereof; US 9,611,179
- Refractory Metal Boride Ceramics and Methods of Making Thereof; US. 8,865,301, US. 9,469,572
- Refractory Metal Borides Ceramics and Methods of Making Thereof; US. 9,637,416
- Formation of Boron Carbide-Boron Nitride Carbon Compositions; US. 8,815,381
Select Publications:
- Materials tested for new and challenging missions, including space habitation | Aerospace Design and Structures
- 3D-printed ceramics | Aerospace America
- Commercially scalable, single-step polymer-derived reaction bionding synthesis of refractory ceramics | American Ceramic Society Bulletin
Contact:
Email: jack@nanoarmor.comPhone: 303-526-6050
Website: www.nanoarmor.com
Portfolio Companies
- Active Membranes, LLC.
- Avesta76 Therapeutics
- Capacity Bio
- CDR3 Therapeutics, Inc.
- Dalton Bioanalytics
- EarlyDx
- Forcyte Biotechnologies
- Gradient Orthodontics
- ImmunoVec
- Lactation Lab
- Lookin, Inc.
- Nanoarmor, LLC.
- Partillion Bioscience Corporation
- Pelage Pharmaceuticals
- Pluto Immunotherapeutics
- Scarless Laboratories
- Sorriso Pharmaceuticals
- Symphony Biosciences
- Vault Pharma
- ViBo Health
- Westwood Bioscience